Guide to Selecting PEG Reagents for Efficient Bioconjugation

Explore PEG Reagents for Bioconjugation Selection

BOC Sciences offers functional PEG reagents for bioconjugation workflows, including Aldehyde PEG, Hydrazide PEG, Maleimide PEG, NHS ester PEG, and Thiol PEG products for amine, thiol, carbonyl, click-ready, lipid-linked, and staged conjugation designs.

Why PEG Reagent Selection Determines Bioconjugation Outcome?

PEG bioconjugation is controlled by multiple variables at the same time. The reactive end group determines chemical compatibility, but the PEG chain, molecular weight distribution, end-group conversion, linker geometry, solvent compatibility, and purification method determine whether the selected reagent will actually produce a useful conjugate. A reagent that performs well for a small molecule may be unsuitable for a folded protein. A PEG spacer that improves solubility may also make mass analysis more complex. A high-reactivity group may hydrolyze or react nonspecifically if the buffer and timing are poorly matched.

Functional Group Compatibility Is Only the First Filter

The first step in PEG reagent selection is identifying which functional group on the target molecule is available for conjugation. Primary amines, cysteine thiols, azides, alkynes, aldehydes, ketones, carboxyl groups, hydroxyl groups, and surface silanols all suggest different PEG reagent families. However, functional group matching alone is not enough. For example, an NHS ester PEG may react with lysine residues on proteins, but the product may be heterogeneous if many lysines are solvent-accessible. A maleimide PEG may react efficiently with a reduced cysteine, but the reaction may suffer if thiols oxidize or if the pH favors maleimide hydrolysis. A clickable PEG may provide high selectivity, but the target must first carry a compatible azide, alkyne, DBCO, or related handle. Selection should therefore begin with chemical compatibility and then move quickly into site control, reaction environment, steric accessibility, and analytical feasibility.

PEG Chain Length Affects Solubility, Sterics, and Analysis

PEG molecular weight and spacer length influence how the conjugate behaves after coupling. Short PEG spacers such as PEG2, PEG4, PEG8, or PEG12 are often useful when precise mass, compact spacing, and LC-MS-friendly analysis are important. Medium PEG chains can improve aqueous solubility and reduce local steric conflict while keeping purification manageable. Longer PEGs can provide stronger hydration, surface shielding, or aggregation reduction, but they may broaden chromatographic peaks, complicate mass assignment, and increase viscosity or handling challenges. For proteins and surfaces, longer PEG chains may improve exposure or spacing; for small molecules and peptides, excessive PEG length may obscure structural confirmation or reduce recovery. A practical PEG linker selection process should choose the shortest PEG length that provides the required solubility, accessibility, and separation effect.

Purity and End-Group Conversion Impact Reproducibility

Functional PEG reagents are often evaluated by apparent molecular weight and terminal group identity, but reproducible bioconjugation depends on more than the product name. End-group conversion, residual starting material, hydrolyzed reactive groups, salt content, free PEG, broad molecular weight distribution, and storage-related degradation can all affect reaction outcome. For sensitive conjugation workflows, the reagent should be selected with realistic analytical needs in mind. Monodisperse PEG can simplify exact mass confirmation, while higher-molecular-weight PEG may require SEC, GPC, NMR, MALDI, or end-group assays rather than relying on a single method. Reactive groups such as NHS ester, maleimide, thiol, aldehyde, and DBCO should be stored and handled according to their stability limits. Inconsistent end-group integrity is one of the most common causes of variable yield, unexpected excess reagent requirements, and difficult purification.

Start from the Reactive Group on the Target Molecule

The most reliable PEG reagent selection workflow begins with the substrate rather than the PEG catalog. Identify which reactive group is naturally present, which one can be introduced without damaging the molecule, and whether modification should be random or site-directed. A protein rich in lysines, a peptide with a terminal cysteine, an oligonucleotide bearing a 5'-azide, a lipid carrying an amine, and a particle surface carrying silanol groups all require different PEG strategies. The selected reagent must match the substrate chemistry while preserving solubility and enabling purification after coupling.

Primary Amines → NHS Ester PEG

Primary amines are commonly found on lysine side chains, N-termini, amino-modified oligonucleotides, aminated surfaces, and amine-containing small molecules. NHS ester PEG is frequently selected for amine-reactive conjugation because it forms stable amide linkages under mild conditions. The reaction is usually performed in aqueous or mixed aqueous-organic systems at mildly basic pH, where the amine is nucleophilic enough to react while NHS hydrolysis remains manageable. The main limitation is selectivity. If multiple amines are available, the product may contain a distribution of modification sites and degrees of PEGylation. For proteins and antibodies, this may require careful control of reagent equivalents, reaction time, pH, temperature, and purification method. For small molecules or synthetic intermediates, NHS ester PEG can be more controlled if a single amine is present and competing nucleophiles are excluded.

Cysteine Thiols → Maleimide PEG, Thiol PEG

Cysteine thiols are valuable for more controlled conjugation because they are often less abundant than lysines and can be introduced at defined positions in peptides or engineered proteins. Maleimide PEG is widely used for thiol-reactive coupling, while Thiol PEG can react with maleimide-, vinylsulfone-, haloacetyl-, disulfide-, or other thiol-compatible partners. Maleimide-thiol conjugation is typically efficient under mildly acidic to neutral pH, but thiol oxidation, disulfide formation, competing thiols, and hydrolysis of maleimide groups must be controlled. When using thiol PEG, the reagent itself may require protection from oxidation and may need reducing or freshly prepared conditions. For antibody fragments, cysteine-containing peptides, thiolated oligonucleotides, and thiol-functionalized surfaces, thiol chemistry can provide a strong route to site-directed or semi-site-directed PEGylation if the thiol state is verified before reaction.

Azide or Alkyne Handles → Clickable PEG

Azide and alkyne handles support click-based PEG bioconjugation, especially when a selective, modular route is needed. Azide PEG and Alkyne PEG can be paired in CuAAC reactions to form stable triazole linkages when copper catalyst compatibility is acceptable. DBCO PEG can react with azide-bearing targets through SPAAC under copper-free conditions, which is useful when residual copper, catalyst removal, or metal sensitivity would complicate the workflow. Clickable PEG reagents are especially useful for staged conjugation, orthogonal labeling, surface functionalization, oligonucleotide modification, and small-molecule linker construction. Selection should consider the size and hydrophobicity of strained alkynes, copper tolerance, reaction speed, steric accessibility, and the ability to remove excess clickable PEG after conjugation.

Carbonyl or Aldehyde → Hydrazide PEG, Aldehyde PEG

Carbonyl-based conjugation is useful when aldehyde or ketone groups are present on oxidized carbohydrates, glycoproteins, oxidized polysaccharides, or synthetic intermediates. Hydrazide PEG can react with aldehydes or ketones to form hydrazone-type linkages, while Aldehyde PEG can be used with hydrazide-, aminooxy-, or amine-containing partners depending on the desired route. These reactions often require careful pH selection because carbonyl condensation can be slow or reversible, and some linkages may require reduction or stabilization depending on the final design. Carbonyl chemistry can be valuable for glycan-rich targets or site-selective oxidation strategies, but over-oxidation, target degradation, and heterogeneous aldehyde generation should be avoided. The PEG reagent should be chosen together with the oxidation method, quenching step, purification method, and final linkage stability requirement.

Match the PEG Reagent to the Biomolecule Type

Different biomolecules create different constraints for PEG bioconjugation reagent selection. Proteins are folded and sensitive to buffer conditions. Antibodies are large, multi-domain structures where random modification may affect binding. Peptides may be easier to analyze but can aggregate or contain multiple competing groups. Oligonucleotides require compatibility with charged backbones and HPLC or PAGE purification. Lipids, nanoparticles, and surfaces require attention to interfaces, density, and accessibility. A useful functional PEG selection strategy must therefore connect the chemistry to the substrate class.

Protein and Enzyme Conjugation

Protein PEGylation requires a balance between chemical conversion and preservation of structure. NHS ester PEG can target lysines or N-termini, but multiple available amines may generate a mixture of positional isomers. Maleimide PEG can be more selective when a free cysteine is available, but the cysteine must remain reduced and accessible. Aldehyde or hydrazide chemistry may be useful for glycoproteins or oxidized carbohydrate regions. Clickable PEG can support site-directed strategies if the protein has been engineered or modified with azide, alkyne, or strained alkyne handles. For enzymes, conjugation near active sites may reduce activity even when chemical yield is high, so PEG length and conjugation site should be chosen with functional testing in mind. Purification usually requires SEC, IEX, HIC, ultrafiltration, SDS-PAGE, or capillary electrophoresis rather than small-molecule methods alone.

Antibody and Fragment Conjugation

Antibodies and antibody fragments require additional attention to binding domain accessibility, interchain disulfides, hinge-region chemistry, and modification distribution. Random lysine PEGylation may be straightforward but can create heterogeneous products. Cysteine-directed maleimide PEGylation may offer better control if reduced hinge thiols or engineered cysteines are available, but over-reduction and reoxidation can create mixtures. Heterobifunctional PEG can be useful when an antibody must be connected to a dye, small molecule, oligonucleotide, lipid, surface, or other module through a staged route. For antibody fragments, PEG size can strongly affect apparent molecular size, purification behavior, and binding accessibility. The selection should therefore consider the conjugation site, linker length, purification method, and functional assay at the same time.

Peptide Conjugation

Peptides often provide more design freedom because reactive residues can be placed intentionally during synthesis. A terminal cysteine can support maleimide PEG coupling, an N-terminal amine can support NHS ester or activated carbonate chemistry, and azide or alkyne handles can support click PEGylation. However, peptide conjugation is not automatically simple. Peptides may contain multiple lysines, cysteines, histidines, acidic residues, or hydrophobic segments that influence reaction selectivity and solubility. Short monodisperse PEG linkers are often useful when exact mass confirmation is needed, while longer PEGs may be selected to improve aqueous handling or reduce aggregation. For peptide conjugates, HPLC and LC-MS are frequently central to method design, so PEG length and dispersity should be chosen with analytical resolution in mind.

Oligonucleotide and Nucleic Acid Conjugation

Oligonucleotide PEG conjugation usually relies on preinstalled functional handles such as amine, thiol, azide, alkyne, DBCO, or other orthogonal groups. Clickable PEG reagents are attractive because they can react selectively with modified oligonucleotides while avoiding broad reaction with the phosphate backbone. Maleimide PEG can react with thiolated oligonucleotides, but thiol oxidation and disulfide formation must be controlled. The charged nature of oligonucleotides affects purification, desalting, and HPLC method development. Short to medium monodisperse PEG spacers are often easier to confirm by mass spectrometry, while longer PEG chains may affect migration and chromatographic separation. The selected PEG reagent should be compatible with aqueous buffers, salt conditions, and the purification system used to remove excess PEG reagent and unmodified oligonucleotide.

Lipid, Nanoparticle, and Surface Conjugation

Lipid, nanoparticle, and surface PEGylation workflows are controlled by interfacial chemistry as much as by molecular reactivity. Lipid PEG, DSPE PEG, cholesterol PEG, silane PEG, thiol PEG, azide PEG, DBCO PEG, and multi-arm PEG may be selected depending on whether the target is a lipid bilayer, polymer particle, gold surface, silica surface, hydrogel, sensor interface, or coating. Longer PEG chains may improve hydration and reduce nonspecific adsorption, but excessive chain length or surface density may block ligand accessibility. Surface reactions also require distinguishing covalent attachment from adsorption. Characterization may require DLS, zeta potential, ligand quantification, contact angle, fluorescence imaging, XPS, ellipsometry, or other surface-specific methods. For these systems, purification is often not a simple chromatographic step; washing, dialysis, centrifugation, filtration, or surface extraction controls may be needed.

Select PEG Molecular Weight and Spacer Length

PEG molecular weight selection should be driven by what the PEG is expected to accomplish. In some projects, PEG is only a short hydrophilic spacer that separates two functional modules. In others, it improves solubility, reduces aggregation, increases hydrodynamic size, shields a surface, or changes the distance between a ligand and a particle. The same PEG length will not be optimal for every substrate. The best selection is usually based on a compromise between conjugate performance, synthetic accessibility, purification feasibility, and analytical clarity.

Fig. 2. PEG architectures for different conjugation designs (BOC Sciences Authorized).

Short PEG Spacers for Compact Conjugates

Short PEG spacers such as PEG2, PEG3, PEG4, PEG6, PEG8, PEG12, or similar discrete units are useful when compact structure and defined mass are important. They are commonly selected for small-molecule conjugates, peptide linkers, oligonucleotide labels, clickable intermediates, and analytical probes. Short PEGs improve hydrophilicity compared with simple alkyl chains while limiting the mass increase and conformational flexibility introduced by the linker. They are also easier to analyze by LC-MS and NMR, especially when monodisperse. The limitation is that short PEGs may not provide enough distance to relieve steric hindrance on a crowded protein surface, nanoparticle, hydrogel, or membrane interface. If the conjugate shows poor accessibility or aggregation, a longer PEG may be required.

Medium PEG for Solubility and Manageable Purification

Medium PEG chains often provide a useful balance between hydrophilicity and purification practicality. They can improve aqueous solubility, reduce local hydrophobic interaction, and create enough distance between bulky modules without making the conjugate excessively broad or difficult to characterize. Medium PEGs are often considered for peptide conjugates, protein modifiers, dye-linkers, affinity probes, small-molecule conjugates, and surface ligands. The exact range depends on whether the PEG is monodisperse or polydisperse and whether the target is small or macromolecular. When prior data are limited, screening two or three medium-length PEG variants can be more informative than assuming a single length will solve solubility, steric, and analytical needs at once.

Long PEG for Surface Shielding and Aggregation Reduction

Long PEG chains are selected when hydration, shielding, steric stabilization, or reduced aggregation is the primary objective. They may be useful for particle surfaces, protein conjugates, hydrophobic molecules, PEG-lipids, and coatings where a larger hydrated layer is desired. Longer PEG can reduce nonspecific adsorption and improve dispersion in some systems, but the effect depends on grafting density, chain conformation, surface curvature, and the nature of the target. Long PEG also introduces challenges. It may create broad distributions, difficult mass analysis, slower diffusion, higher viscosity, lower coupling efficiency, and more difficult removal of free PEG. Long PEG should therefore be chosen only when its benefits are necessary and when the purification and characterization workflow can handle the added complexity.

Screening PEG Lengths When Prior Data Is Unavailable

When there is no prior information for a target, a small PEG length screen is often more reliable than selecting a single reagent by intuition. A practical screen may include one short spacer for analytical clarity, one medium spacer for solubility balance, and one longer PEG for shielding or aggregation reduction. The output should not be judged only by reaction yield. Compare conjugate purity, recovery, solubility, aggregation state, functional accessibility, and analytical behavior. For proteins, SEC profile and activity or binding readout may be more informative than conversion alone. For oligonucleotides, HPLC resolution and mass confirmation may dominate. For surfaces, ligand accessibility and washing stability may matter more than nominal loading. PEG length selection is therefore an optimization variable, not merely a catalog preference.

Choose PEG Architecture for Bioconjugates

PEG architecture defines how many functional groups are present, where they are placed, whether the reagent modifies one site or connects two modules, and how much structural control is possible. Linear, methoxy-terminated, homobifunctional, heterobifunctional, multi-arm, and monodisperse PEG reagents serve different purposes. Choosing the wrong architecture can create unwanted crosslinking, mixed products, poor end-group accessibility, or unnecessary synthetic complexity. The correct architecture should follow the intended conjugation design.

Linear PEG for Simple Spacing

Linear PEG structures are used when the main requirement is to add distance, hydrophilicity, or flexibility between a target and a functional group. A linear PEG may contain one reactive end and one inert end, or two functional ends depending on the design. It is often selected for straightforward biomolecule labeling, small-molecule linker construction, peptide modification, and surface ligand spacing. Linear PEG is usually easier to interpret than branched or multi-arm structures because the relationship between spacer length and conjugate geometry is more direct. However, linear PEG still requires careful selection of end group, molecular weight, and purity. If two reactive ends are present, crosslinking may occur unless stoichiometry and reaction order are controlled.

Methoxy-Terminated PEG for Single-End Modification

Methoxy Linear PEG (mPEG) is commonly used when only one end of the PEG chain should participate in conjugation. The methoxy end is generally inert under many bioconjugation conditions, while the other end carries an activated group such as NHS ester, maleimide, aldehyde, thiol, amine, carboxyl, azide, or alkyne. This architecture is useful when the goal is to attach one PEG chain to a protein, peptide, small molecule, particle, or surface without creating bridging between two targets. mPEG reagents are frequently chosen to improve solubility, modify apparent size, or reduce nonspecific surface interaction. The key selection point is the reactive end group and molecular weight, because the methoxy terminus mainly prevents further reaction rather than controlling conjugation specificity.

Homobifunctional PEG for Symmetric Bridging

Homobifunctional PEG contains the same reactive group at both ends and is useful when symmetric bridging, crosslinking, or two-point attachment is desired. Examples include NHS-PEG-NHS, maleimide-PEG-maleimide, thiol-PEG-thiol, azide-PEG-azide, and alkyne-PEG-alkyne designs. These reagents can connect two amine-bearing molecules, two thiol-bearing molecules, two clickable partners, or two surface sites depending on chemistry. The main risk is uncontrolled crosslinking or network formation if both ends react with multiple targets in solution. Homobifunctional PEG should be selected when symmetric reactivity is intentional and when stoichiometry, concentration, and reaction sequence can be controlled. For simple one-target modification, a monofunctional or methoxy-terminated PEG is usually safer.

Heterobifunctional PEG for Staged Conjugation

Heterobifunctional PEG contains two different functional groups, allowing stepwise connection of two different modules. This architecture is central to many bioconjugation workflows because one end can react with a biomolecule while the other end carries a click handle, affinity tag, lipid anchor, dye-reactive group, or surface-reactive group. For example, NHS-PEG-maleimide can connect amine-bearing and thiol-bearing partners, while azide-PEG-NHS can introduce a click handle onto an amine-containing substrate. Heterobifunctional PEG selection requires planning the reaction order. The more labile or more selective group is often used first, while the second group must survive the first reaction and purification. This architecture is powerful but demands careful control of pH, solvent, storage, and purification to avoid losing one end-group before it is used.

Multi-Arm PEG for Network Formation and High-Density Functionalization

Multi-Arm PEG contains multiple PEG chains or functional groups radiating from a central core. It is useful for hydrogel formation, surface coating, network construction, multivalent ligand display, and high-density functionalization. Multi-arm PEG can increase local functionality and support crosslinked structures, but it also increases the risk of rapid gelation, heterogeneous substitution, steric crowding, and difficult analysis. In bioconjugation, multi-arm PEG should be selected only when multivalency or network formation is required. Functional group conversion, arm number, molecular weight per arm, total molecular weight, and reaction stoichiometry all affect performance. For biomolecule modification, excessive local functionality can reduce accessibility or create mixtures unless the design is tightly controlled.

Monodisperse PEG for Precise Mass and Analytical Clarity

Monodisperse PEG provides a defined number of ethylene glycol units, which can greatly simplify LC-MS, NMR, HPLC method development, and structure-property interpretation. It is especially valuable for small-molecule conjugates, peptide linkers, oligonucleotide conjugates, clickable probes, and research tools where exact mass and batch-to-batch consistency are important. Compared with polydisperse PEG, monodisperse PEG reduces molecular weight distribution effects and makes it easier to assign product identity. The tradeoff is that longer monodisperse PEGs may require more complex synthesis and may have different availability compared with standard polydisperse PEGs. When analytical clarity is a major requirement, monodisperse PEG is often worth prioritizing early in the design rather than switching after problems appear.

Consider Downstream Purification and Characterization Needs

PEG reagent selection should always include a purification and characterization plan before the reaction is performed. Many PEG bioconjugation failures are not caused by the coupling chemistry itself, but by the inability to separate the product from free PEG, unmodified target, partially modified species, hydrolyzed reagent, salts, catalyst residues, or aggregates. A reagent that is chemically suitable may still be impractical if the final mixture cannot be resolved or analyzed with available methods.

Small PEG Conjugates → HPLC, LC-MS, NMR

Small molecules, peptide-linker intermediates, dye-linkers, and short PEG conjugates are often evaluated by HPLC, LC-MS, and NMR. For these workflows, monodisperse or short PEG reagents are usually preferred because they produce cleaner mass spectra and more interpretable chromatograms. Broad PEG distributions may create overlapping peaks and complicated mass envelopes, making it difficult to distinguish complete product from partially converted intermediates. Solvent selection is also important because some PEG conjugates retain water, interact strongly with chromatographic phases, or elute broadly. When the goal is exact structure confirmation, choose PEG reagents that can be analyzed by the methods available rather than selecting a high-molecular-weight PEG that obscures product identity.

Proteins → SEC, IEX, HIC, SDS-PAGE, CE

Protein and antibody PEG conjugates are usually characterized with methods that evaluate size, charge, hydrophobicity, electrophoretic mobility, and product distribution. Size exclusion chromatography can separate conjugates by apparent hydrodynamic size, while ion exchange chromatography can resolve charge variants created by modification. Hydrophobic interaction chromatography may be useful when PEGylation changes surface hydrophobicity. SDS-PAGE and capillary electrophoresis can help compare unmodified and modified species, although PEG can alter migration behavior in ways that require careful interpretation. For protein conjugates, the selected PEG reagent should support a purification strategy that removes free PEG without damaging the protein. Excess reagent may improve conversion but can make purification more difficult, especially for high-molecular-weight PEG.

Oligonucleotides → HPLC, PAGE, Desalting, Ultrafiltration

Oligonucleotide PEG conjugates require methods that can handle charged, hydrophilic molecules and remove salts, excess PEG reagent, and unmodified oligonucleotide. Ion-pair reverse-phase HPLC, anion exchange HPLC, PAGE, desalting columns, dialysis, and ultrafiltration may be used depending on size and chemistry. Short monodisperse PEGs usually support clearer mass confirmation, while longer PEGs may change retention, broaden peaks, or alter gel migration. Clickable PEG reagents are often suitable because they provide selective ligation to installed handles, but excess hydrophobic DBCO-bearing reagents or dye-bearing PEGs may require careful cleanup. The purification plan should be matched to the oligonucleotide length, modification site, PEG size, and acceptable salt or solvent conditions.

Nanoparticles and Surfaces → DLS, Zeta Potential, Ligand Quantification, Contact Angle

PEGylated particles and surfaces require characterization methods that confirm both chemical modification and interfacial behavior. Dynamic light scattering can reveal changes in particle size or aggregation. Zeta potential can show changes in surface charge after PEG attachment or ligand introduction. Ligand quantification can estimate loading, but loading does not always equal accessibility. Contact angle, fluorescence imaging, XPS, ellipsometry, and surface-binding assays may help evaluate coating or surface modification. PEG reagent selection should account for how the reagent anchors to the surface, how much PEG density is desired, and whether the terminal group remains accessible after attachment. For particles and surfaces, washing stability and control experiments are essential because adsorbed PEG or trapped free reagent can mimic successful conjugation.

Avoiding Issues from Broad PEG Distributions, Free PEG, Copper Residues, and Partially Modified Products

Several recurring impurities can make PEG conjugation results difficult to interpret. Broad PEG distributions can create product heterogeneity and complicate quantification. Free PEG can interfere with assays, alter viscosity, or overlap with the product during purification. Copper residues from CuAAC reactions can affect sensitive biomolecules or downstream analysis if not removed. Partially modified products can appear when multiple reactive sites are present or when stoichiometry is insufficient. To reduce these risks, choose monodisperse PEG where exact identity is needed, use copper-free SPAAC where catalyst removal is problematic, verify reactive end-group integrity before reaction, and design purification around the most difficult impurity rather than only the expected product. For deeper troubleshooting after a reaction has already produced unexpected results, see troubleshooting PEG bioconjugation.

Structured PEG Reagent Selection Workflow

A structured workflow helps avoid selecting a PEG reagent based only on a familiar functional group or a single catalog category. The goal is to move from substrate chemistry to final product requirements in a logical order. Each step should narrow the options and expose potential problems before synthesis begins.

How BOC Sciences Supports PEG Reagent Selection?

BOC Sciences supports PEG reagent selection for research bioconjugation workflows involving proteins, antibodies, peptides, oligonucleotides, small molecules, lipids, nanoparticles, surfaces, and functional materials. Support can be tailored to functional group matching, PEG molecular weight screening, linker architecture design, custom PEG synthesis, reaction feasibility review, purification planning, and analytical method recommendation. The objective is to help researchers select PEG reagents that are chemically compatible, experimentally practical, and aligned with the final conjugate requirements.

Functional PEG Screening

• Recommend PEG reagent families based on available amines, thiols, azides, alkynes, aldehydes, carboxyl groups, lipid anchors, or surface groups.
• Compare NHS ester PEG, maleimide PEG, thiol PEG, azide PEG, alkyne PEG, DBCO PEG, aldehyde PEG, hydrazide PEG, and related functional PEG options.
• Support PEG molecular weight screening when solubility, steric accessibility, aggregation, or purification behavior is uncertain.
• Help identify whether monofunctional, bifunctional, heterobifunctional, multi-arm, or monodisperse PEG is more suitable for the target design.

Custom PEG Design and Synthesis

• Design custom PEG linkers with selected molecular weight, terminal groups, spacer length, and architecture for staged bioconjugation workflows.
• Support heterobifunctional PEG structures for connecting biomolecules, small molecules, dyes, lipids, surfaces, or click handles in a controlled sequence.
• Develop monodisperse PEG linkers when exact mass, LC-MS clarity, defined spacing, or batch consistency is required.
• Evaluate route feasibility before synthesis to reduce risks from incompatible end groups, unstable intermediates, or difficult purification.

PEGylation Service Support

• Support PEGylation strategy design for proteins, antibodies, peptides, oligonucleotides, small molecules, lipids, nanoparticles, and surfaces.
• Recommend PEGylation routes based on amine, thiol, click, carbonyl-directed, lipid-linked, or surface-reactive chemistry.
• Optimize PEG reagent ratio, buffer, pH, solvent, reaction time, temperature, and substrate compatibility.
• Support purification and verification by removing free PEG, unmodified substrate, partial products, catalysts, and byproducts.

End-Group Selection Guidance

• Select reactive groups according to substrate chemistry, including amine-reactive, thiol-reactive, click-ready, carbonyl-reactive, lipid-linked, and surface-reactive PEG reagents.
• Review pH, buffer, co-solvent, temperature, storage, and handling requirements for labile PEG end groups.
• Help choose between CuAAC, SPAAC, thiol-Michael, amide formation, hydrazone formation, silane coupling, or staged heterobifunctional routes.
• Reduce risks related to hydrolysis, thiol oxidation, nonspecific reaction, incomplete conversion, and loss of end-group activity.